Safety of guselkumab in patients with psoriasis with a history of malignancy : 5-year results from the VOYAGE 1 and VOYAGE 2 trials
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:189 |
---|---|
Enthalten in: |
The British journal of dermatology - 189(2023), 1 vom: 07. Juli, Seite 132-134 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Blauvelt, Andrew [VerfasserIn] |
---|
Links: |
---|
Themen: |
089658A12D |
---|
Anmerkungen: |
Date Completed 10.07.2023 Date Revised 20.11.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/bjd/ljad081 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM354498142 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM354498142 | ||
003 | DE-627 | ||
005 | 20231226062343.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/bjd/ljad081 |2 doi | |
028 | 5 | 2 | |a pubmed24n1181.xml |
035 | |a (DE-627)NLM354498142 | ||
035 | |a (NLM)36944555 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Blauvelt, Andrew |e verfasserin |4 aut | |
245 | 1 | 0 | |a Safety of guselkumab in patients with psoriasis with a history of malignancy |b 5-year results from the VOYAGE 1 and VOYAGE 2 trials |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.07.2023 | ||
500 | |a Date Revised 20.11.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a guselkumab |2 NLM | |
650 | 7 | |a 089658A12D |2 NLM | |
650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
650 | 7 | |a Adalimumab |2 NLM | |
650 | 7 | |a FYS6T7F842 |2 NLM | |
700 | 1 | |a Thaçi, Diamant |e verfasserin |4 aut | |
700 | 1 | |a Papp, Kim A |e verfasserin |4 aut | |
700 | 1 | |a Ho, Vincent |e verfasserin |4 aut | |
700 | 1 | |a Ghoreschi, Kamran |e verfasserin |4 aut | |
700 | 1 | |a Kim, Byung Soo |e verfasserin |4 aut | |
700 | 1 | |a Miller, Megan |e verfasserin |4 aut | |
700 | 1 | |a Shen, Yaung-Kaung |e verfasserin |4 aut | |
700 | 1 | |a You, Yin |e verfasserin |4 aut | |
700 | 1 | |a Chan, Daphne |e verfasserin |4 aut | |
700 | 1 | |a Yu, Jenny |e verfasserin |4 aut | |
700 | 1 | |a Yang, Ya-Wen |e verfasserin |4 aut | |
700 | 1 | |a Lebwohl, Mark G |e verfasserin |4 aut | |
700 | 1 | |a Gottlieb, Alice B |e verfasserin |4 aut | |
700 | 1 | |a Crowley, Jeffrey |e verfasserin |4 aut | |
700 | 1 | |a Foley, Peter |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The British journal of dermatology |d 1951 |g 189(2023), 1 vom: 07. Juli, Seite 132-134 |w (DE-627)NLM000000361 |x 1365-2133 |7 nnns |
773 | 1 | 8 | |g volume:189 |g year:2023 |g number:1 |g day:07 |g month:07 |g pages:132-134 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/bjd/ljad081 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 189 |j 2023 |e 1 |b 07 |c 07 |h 132-134 |